Skip to main content

CITADEL ADVISORS LLC

Position in APRE — Aprea Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in APRE

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$46,997
+$3,460 QoQ
Shares Held
58,600
+14.8% QoQ
Ownership
0.465%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 28 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APRE Over Time

Shares Held

Position Value (USD)

Derivatives in APRE

reported options exposure · as of Dec 31, 2022
CallValue
$106,681
CallShares
16,115
PutValue
$3,872
PutShares
585

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,149,545,836 across 435 Biotechnology names. APRE ranks #386 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APRE

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $46,997 58,600
2025-12-31 $43,537 51,041
2025-03-31 $61,369 30,083
2022-12-31 $106,681 322,300
2022-12-31 $3,872 11,700
2022-12-31 $422 1,276
2022-09-30 $7,670 11,800
2022-09-30 $215,865 332,100
2022-06-30 $9,000 12,000
2022-06-30 $14,160 18,881
2022-06-30 $274,425 365,900
2022-03-31 $143,372 77,082
2022-03-31 $682,992 367,200
2021-12-31 $264,614 92,200
2021-12-31 $468,558 163,261
2021-12-31 $149,527 52,100
2021-09-30 $243,747 47,700
2021-09-30 $544,215 106,500
2021-09-30 $623,159 121,949
2021-06-30 $139,660 28,619
2021-06-30 $203,984 41,800
2021-06-30 $104,920 21,500
2021-03-31 $88,740 17,400
2021-03-31 $117,810 23,100
2020-09-30 $1,782,195 74,073
2020-06-30 $11,981,003 308,948
2020-03-31 $11,166,336 321,241